Invention Grant
US08158583B2 Soluble pharmaceutical compositions for parenteral administration comprising a GLP-1 peptide and an insulin peptide of short time action for treatment of diabetes and bulimia
有权
用于肠胃外给药的可溶性药物组合物，其包含用于治疗糖尿病和贪食症的GLP-1肽和短时间作用的胰岛素肽
- Patent Title: Soluble pharmaceutical compositions for parenteral administration comprising a GLP-1 peptide and an insulin peptide of short time action for treatment of diabetes and bulimia
- Patent Title (中): 用于肠胃外给药的可溶性药物组合物，其包含用于治疗糖尿病和贪食症的GLP-1肽和短时间作用的胰岛素肽
-
Application No.: US12464444Application Date: 2009-05-12
-
Publication No.: US08158583B2Publication Date: 2012-04-17
- Inventor: Liselotte Bjerre Knudsen , Kristian Tage Hansen , Dorthe Kot Engelund , Svend Ludvigsen , Lars Hansen , Claude Bonde , Ejvind Jensen , Tine Elisabeth Gottschalk Bøving , Morten Schlein
- Applicant: Liselotte Bjerre Knudsen , Kristian Tage Hansen , Dorthe Kot Engelund , Svend Ludvigsen , Lars Hansen , Claude Bonde , Ejvind Jensen , Tine Elisabeth Gottschalk Bøving , Morten Schlein
- Applicant Address: DK Bagsvaerd
- Assignee: Novo Nordisk A/S
- Current Assignee: Novo Nordisk A/S
- Current Assignee Address: DK Bagsvaerd
- Agent Teresa Chen
- Priority: DK200301689 20031113
- Main IPC: A61K38/26
- IPC: A61K38/26 ; A61K38/28
Abstract:
Pharmaceutical composition for parenteral administration comprising a meal related insulin peptide and an insulinotropic peptide.
Public/Granted literature
Information query
IPC分类:
